Navigation Links
An In-Depth Understanding of the Chinese Pharmaceutical Industry
Date:10/1/2013

MUMBAI, October 1, 2013 /PRNewswire/ --

Bharat Book Bureau Presents Pharmaceutical Industry China - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges. ( http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html )

     (Logo: http://photos.prnewswire.com/prnh/20130128/590935)

It is a comprehensive report on the pharmaceutical and biotechnology industry in China and its impact on international markets. This report tackles not only global pharmaceutical company interest in China but also home grown companies and their battle for position. The business environment in which they compete is analyzed as are key drivers, constraints, challenges and opportunities.

A wealth of financial information is provided including:

  • Company financials, sales & revenue figures - historical to Q2•2013
  • China GDP, economic growth, export (bulk drug, formulations) figures
  • Indian health expenditure as a function of GDP
  • Growth change figures of emerging and developing countries (India, Russia, China, Brazil)
  • Economic growth figures of advanced economies (USA, UK, Germany, France, Italy, Spain, Japan, Canada)
  • Projected figures of strategic emerging industry GDP percentage contribution

SWOT, Economic and Business Environment specifics include:

  • Key strengths, weaknesses and threats influencing leading player position within the market
  • Top Five Contract Pharmaceutical Export Markets of China
  • Major players within China's leading therapeutic markets (e.g., cancer, allergy, liver disease)
  • Multinational penetration into the Chinese Pharma Market
  • Comprehensive product portfolios, R&D activity and pipeline therapeutics
  • M&A activity and future strategies of top Chinese pharmacos
  • Economic indicators, trade policy, merchandise and commercial trade statistics
  • Gross Domestic Product of China, historic and projection analysis
  • Chinese economic outlook in comparison to advanced economies
  • Three Tier 'Pharmerging' Markets with Potential for Significant Growth
  • Prescription drug sales distribution channels in China
  • Major Biogeneric products in China

The Chinese biopharmaceutical market is presented as follows:

  • By Company (e.g., AMOYTOP BIOTECH, BEIJING CONTINENT PHARMACEUTICALS, FUSOGEN, SHANGHAI HUAGUAN BIOCHIP, SIBIONO GENETECH, ABBOTT, ROCHE, PFIZER, GSK, NOVARTIS)
  • By Therapeutic Area (e.g., Anti-infective, Cancer, Diabetes, Dementia, Depression)

What you will gain:

  • An in-depth understanding of the Chinese biopharmaceutical market and it's environment
  • Current market facts, figures and product lines of key players in the industry
  • An insight into how generic therapeutics will propagate the Chinese biopharmaceutical market
  • Knowledge of how the Chinese pharma market will integrate into the global healthcare market
  •  Information on key regulatory and government policies
  •  Data on levels of private and publically funded biopharma studies in China
  • Strategies on how to adapt and restructure current business models to this industry

Key concerns to the Chinese biopharmaceutical market such as:

  • Lack of regulatory policy and legislation
  • Reimbursement schemes and payers concerns
  • Funding and government sponsorship issues
  • International scepticism of Chinese safety and efficacy therapeutic profiles

This report will tell you if the companies mentioned are:

  • Strong, competitive players
  • Pooling their resources for specific growth and therapeutic areas
  • Investing strategically in R&D
  • Have a history of strategic M&A activity

Covers significant Chinese and multinational pharmacos and gives details of their operations, products, financials and business strategy:

  • Amoytop Biotech
  • Active Pharmaceutical Products
  • Beijing Continent Pharmaceuticals
  • FusoGen Pharmaceuticals
  • Shanghai Huaguan Biochip
  • SiBiono GeneTech
  • Abbott
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly
  • GlaxoSmithKline
  • Johnson & Johnson Medical
  • Merck
  • Novartis
  • Pfizer
  • Roche

Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=408064

For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/pharmaceutical-industry-china.html

Related Reports:


Related Category:


About Bharat Book Bureau

Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.

Contact us:
Poonam
Bharat Book Bureau
UK: +44 7405 208461
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Skype - bharatbook
E-mail: poonam@bharatbook.com
Website: http://www.bharatbook.com
Live Chat - http://bit.ly/19m3TU4


'/>"/>
SOURCE Bharat Book Bureau
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. The Global Metabolomics Market 2013 Report: An In-Depth Analysis and Forecast of the Market Covering the Leading Competitors in Metabolomics
2. In-Depth Black Mold Removal Guide Released by My Cleaning Products, Company Offers Complimentary Sample of Molderizer and Safe Shield Along With It
3. BioInformatics LLC Multi-Sponsor Market Report – In-depth Exploration of the U.S. Market for Biosimilar Drugs
4. Dr. Ira Williams, Health Care Consultant, Recognizes How Health Care “Best of Intentions” Can Illustrate Lack of Understanding
5. ChanTest Initiates Project for the US FDA to Improve Understanding of the Interaction of Tobacco Products with Human Nicotinic Receptors
6. Understanding interface properties of graphene paves way for new applications
7. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
8. Understanding the molecular mechanisms underlying Alzheimers disease
9. Study led by GW professor provides better understanding of waters freezing behavior at nanoscale
10. Kitware to Develop an In Situ Cosmology Analysis Framework for Increased Understanding of the Universe
11. Genomic Health Announces Results from Two Studies Demonstrating Innovations in Next Generation Sequencing From Paraffin Tissue, Enhancing Understanding of Tumor Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
(Date:2/26/2017)... ... ... Rob Lowe is a well recognized television personality, so it seems natural he ... are important to the American public and important to society at large. An upcoming ... around the world for a few years. , The climate and how we relate ...
(Date:2/24/2017)... ... 2017 , ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, ... Health (NIMH) for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ... to deliver therapeutic levels of olanzapine for a period of 3 months., “We are ...
(Date:2/24/2017)... 24, 2017  Aethlon Medical, Inc. (Nasdaq: ... its Chairman and CEO, Jim Joyce . ... Conference last Saturday, Bill Gates warned world ... people than nuclear weapons. Mr. Gates expressed his concern, ... agencies, that scientific terrorists have access to the necessary ...
Breaking Biology Technology:
(Date:1/31/2017)... 31, 2017  Spero Therapeutics, LLC, a biopharmaceutical ... treatment of bacterial infections, today announced it has ... from Pro Bono Bio Ltd (PBB) to bolster ... resistant forms of Gram-negative bacteria.   The assets acquired ... a PBB group company. "The acquisition ...
(Date:1/25/2017)... Jan. 25, 2017 The Elements of Enterprise ... lifecycle is comprised of a comprehensive set of ... of maintaining digital identities and providing a secured ... There are significant number of programs opted by ... time by optimizing processes and changing policies. However, ...
(Date:1/21/2017)... Research and Markets has announced the addition of the ... offering. ... global voice recognition biometrics market to grow at a CAGR of ... the present scenario and the growth prospects of the global voice ... report considers the revenue generated from the sales of voice recognition ...
Breaking Biology News(10 mins):